期刊文献+

紫杉醇脂质体联合5-Fu/CF新辅助化疗对胃癌细胞凋亡和增殖的影响 被引量:1

Impact of New Adjuvant Chemotherapy with Paclitaxel Liposome Plus 5-Fu/CF on Apoptosis and Proliferation of Gastric Cancer Cells
原文传递
导出
摘要 [目的]探讨紫杉醇脂质体联合5-氟尿嘧啶(5-Fu)/亚叶酸钙(CF)新辅助化疗方案对胃癌细胞凋亡率和增殖率的影响及机制。[方法]应用TUNEL检测凋亡率,SP免疫组化方法检测增殖率和survivin、bcl-2及bax表达情况。[结果]给予新辅助化疗后胃癌细胞凋亡率28.87%±3.05%,增殖率37.26%±2.06%,survivin表达阳性率43.08%,bax表达阳性率47.69%,与化疗前相对指标比较(13.76%±2.37%、56.17%±1.26%、72.31%和23.08%),差异有统计学意义(P<0.05)。[结论]以紫杉醇脂质体+5-Fu/CF作为胃癌术前辅助化疗方案,可以明显提高胃癌细胞凋亡率和抑制其增殖率,其机制可能与下调survivin表达和bcl-2/bax比例有关。
出处 《中国肿瘤》 CAS 2008年第8期711-713,共3页 China Cancer
  • 相关文献

参考文献10

  • 1Sarid D, Ron IG, Sperber F, et al. Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase Ⅱ study[J]. Clin Drug Investig, 2006, 26(12):691-701.
  • 2Takada J, Katsuki Y, Hamada H, et al. Two cases of inoperable gastric cancer successively treated with TS-1 + CDDP as neoadjuvant chemotherapy [J]. Gan To Kagaku Ryoho, 2006, 33(12): 1897-1899.
  • 3程向东.术前新辅助治疗在进展期胃癌中的研究进展[J].中国肿瘤,2008,17(5):396-398. 被引量:3
  • 4Hinnis AR, Luckett JC, Walker RA. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients[J]. Br J Cancer,2007,96(4):639-645.
  • 5罗素霞,陈小兵,闫明,马杰.术前紫杉醇化疗对肺腺癌组织Survivin表达和血管生成的影响[J].中国肿瘤临床,2007,34(17):989-991. 被引量:1
  • 6陈小兵,罗素霞,肖毅军.紫杉醇联合卡培他滨治疗晚期胃癌临床观察[J].中华肿瘤防治杂志,2006,13(14):1115-1116. 被引量:18
  • 7Lundberg BB,Risovic V,Ramaswamy M, et al. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration[J]. J Controlled Release, 2003, 86(1): 93-100.
  • 8Zhang XF, Li YX, Chen XS, et al. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate[J]. Bio-materials, 2005, 26(14): 2121-2128.
  • 9王佳蕾,洪小南,印季良,杜敏琼,周彩存,熊建萍,徐农,陈颖波,许立功,侯惠民.紫杉醇脂质体与紫杉醇治疗非小细胞肺癌64例和乳腺癌62例的疗效[J].中国新药与临床杂志,2006,25(1):1-4. 被引量:19
  • 10Holvoet C, Vander Heyden Y, Lories G, et al. Preparation and evaluation of paelitaxel-containing liposomes[J]. Pharmazie, 2007, 62(2): 126-132.

二级参考文献20

共引文献35

同被引文献11

  • 1王玲,李侠,薛玉文,张霞.非小细胞肺癌Survivin VEGF基因表达及相互关系的探讨[J].中国肿瘤临床,2004,31(22):1302-1304. 被引量:7
  • 2王佳蕾,洪小南,印季良,杜敏琼,周彩存,熊建萍,徐农,陈颖波,许立功,侯惠民.紫杉醇脂质体与紫杉醇治疗非小细胞肺癌64例和乳腺癌62例的疗效[J].中国新药与临床杂志,2006,25(1):1-4. 被引量:19
  • 3陈小兵,罗素霞,肖毅军.紫杉醇联合卡培他滨治疗晚期胃癌临床观察[J].中华肿瘤防治杂志,2006,13(14):1115-1116. 被引量:18
  • 4Sarid D, Ron IG, Sperber F, et al. Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase Ⅱ study[J]. Clin Drug Investig,2006, 26(12) : 691 -701.
  • 5Takada J, Katsuki Y, Hamada H, et al. Two cases of inoperable gastric cancer successively treated with TS-1 + CDDP as neoadjuvant chemotherapy [ J ]. Gan To Kagaku Ryoho, 2006, 33 ( 12 ) : 1897 - 1899.
  • 6Hinnis AR, Luekett JC, Walker RA. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients[J]. Br J Cancer,2007, 96(4) : 639 -645.
  • 7Okada E, Murai Y, Matsui K. Survivin expression in tumor cell nuclei is p redicative of a favorable prognosis in gastric cancer patients[J]. Cancer Lett, 2003, 163( 1 ) : 109 - 116.
  • 8Lundberg BB, Risovic V, Ramaswamy M, et al. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration [ J ]. J Controlled Release, 2003, 86 ( 1 ) : 93 -100.
  • 9Zhang XF, Li YX, Chen XS, et al. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate [ J ]. Bio-materials, 2005, 26(14): 2121 -2128.
  • 10程向东.术前新辅助治疗在进展期胃癌中的研究进展[J].中国肿瘤,2008,17(5):396-398. 被引量:3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部